IMIHGOM and Mimetas are jointly organising a symposium focused on ‘Emerging Technologies in Drug Discovery and Development’. The symposium will take place on Thursday, August 23rd on the Leiden BioScience Park.
A panel of interesting speakers have been lined up, including Marco de Boer (NTrans Technologies); Tomas Bos (Glycostem); and Frank Beurskens (Genmab). Each speaker will address the scientific implications of their company’s technology in drug discovery and development programmes. In addition, two students will present their business development internships.
Attendance is free, kindly register by sending an email to email@example.com. The closing day for registration is Tuesday August 21st. Walk-ins are welcome.
Thursday, August 23, 2018
Biopartner Building 1 (Auditorium)
J.H. Oortweg 21, 2333 CH, Leiden
- 14:30 Walk-in
- 15:00 NTrans Technologies – Marco de Boer (CEO)
‘iTOP: CRISPR delivery with a pinch of salt’
- 15:40 IMIHGOM B.V. – Olivier Smulders (Intern)
‘Technology landscape in oncology drug discovery and drug development’
- 16:00 Mimetas – Karin de Nijs (Intern)
- 16:20 Break
- 16:40 Glycostem – Tomas Bos (Senior Research Manager)
‘CAR-NK: the big promise for a universal cancer cure’
- 17:20 Genmab – Frank Beurskens (Senior Scientist)
‘Translating antibody structure-function relations into therapy: the power of imagination’
- 18:00 Drinks